{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:33:51Z","timestamp":1790984031068,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.atherosclerosis.2004.10.032","type":"journal-article","created":{"date-parts":[[2004,12,16]],"date-time":"2004-12-16T05:30:23Z","timestamp":1103175023000},"page":"387-393","source":"Crossref","is-referenced-by-count":14,"title":["The common insertional polymorphism in the APOC1 promoter is associated with serum apolipoprotein C-I levels in Hispanic children"],"prefix":"10.1016","volume":"179","author":[{"given":"Neil S.","family":"Shachter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Rabinowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheldon","family":"Stohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Conde-Knape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Cohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Deckelbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Berglund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib1","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1194\/jlr.M200210-JLR200","article-title":"Overexpression of apoC-I in apoE-null mice: severe hypertriglyceridemia due to inhibition of hepatic lipase","volume":"43","author":"Conde-Knape","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib2","doi-asserted-by":"crossref","first-page":"8303","DOI":"10.1016\/S0021-9258(19)70647-4","article-title":"Regulation of the hepatic uptake of triglyceride-rich lipoproteins in the rat: opposing effects of homologous apolipoprotein E and individual C apolipoproteins","volume":"255","author":"Windler","year":"1980","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib3","doi-asserted-by":"crossref","first-page":"14642","DOI":"10.1016\/S0021-9258(18)33329-5","article-title":"The effect of human C apolipoproteins on the in vitro hepatic metabolism of triglyceride emulsions in the rat","volume":"257","author":"Quarfordt","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/0264-6021:3380281","article-title":"Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adeno virus-mediated gene delivery of the low-density lipoprotein receptor, but not by the very-low-density-lipoprotein receptor","volume":"338","author":"Jong","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib5","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1172\/JCI118857","article-title":"Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein CI","volume":"98","author":"Shachter","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib6","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1172\/JCI119036","article-title":"In the absence of the low density lipoprotein receptor, human apolipoprotein C-I overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway","volume":"98","author":"Jong","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1172\/JCI791","article-title":"Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein C1","volume":"101","author":"Jong","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib8","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1161\/01.CIR.88.6.2762","article-title":"Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events","volume":"88","author":"Phillips","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/01.ATV.11.3.653","article-title":"Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease","volume":"11","author":"Groot","year":"1991","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib10","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1161\/01.ATV.15.11.1829","article-title":"Association of postprandial triglyceride and retinyl palmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle-aged men and women","volume":"15","author":"Ginsberg","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib11","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1161\/01.ATV.15.12.2122","article-title":"Association of postprandial triglyceride and retinyl palmitate responses with asymptomatic carotid artery atherosclerosis in middle-aged men and women: the atherosclerosis risk in communities (ARIC) study","volume":"15","author":"Sharrett","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.101.3.227","article-title":"Accumulation of apolipoproteins C-I-rich and cholesterol-rich VLDL remnants during exaggerated postprandial triglyceridemia in normolipidemic patients with coronary artery disease","volume":"101","author":"Bj\u00f6rkegren","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib13","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1161\/01.ATV.0000029972.42487.42","article-title":"Postprandial enrichment of remnant lipoproteins with apoC-I in healthy normolipidemic men with early asymptomatic atherosclerosis","volume":"22","author":"Bj\u00f6rkegren","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib14","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1194\/jlr.M200055-JLR200","article-title":"Plasma kinetics of VLDL and HDL apoC-I in normolipidemic and hypertriglyceridemic subjects","volume":"43","author":"Cohn","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib15","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/S0006-291X(88)80424-8","article-title":"Exact localization of the familial dysbetalipoproteinemia associated HpaI restriction site in the promoter region of the APOC-I gene","volume":"152","author":"Smit","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0022-2275(20)33338-1","article-title":"A common HpaI RFLP of apolipoprotein C-I increases gene transcription and exhibits an ethnically distinct pattern of linkage disequilibrium with the alleles of apolipoprotein E","volume":"40","author":"Xu","year":"1999","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib17","first-page":"1001","article-title":"Haplotype analysis of the apolipoprotein E and apolipoprotein C1 loci in Portugal and S\u00e3o Tom\u00e9 e Pr\u00edncipe (Gulf of Guinea): linkage disequilibrium evidence that APOE*4 is the ancestral APOE allele","volume":"71","author":"Seixas","year":"1999","journal-title":"Hum Biol"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib18","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/ajcn\/72.5.1119","article-title":"Predictors of postprandial triacylglycerol response in children: the Columbia University BioMarkers Study","volume":"72","author":"Couch","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib19","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/aje\/152.3.212","article-title":"Inverse association of physical fitness with plasma fibrinogen level in children: the Columbia University BioMarkers Study","volume":"152","author":"Isasi","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib20","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1006\/nbdi.2001.0441","article-title":"Apolipoprotein C-I expression in the brain in Alzheimer's disease","volume":"8","author":"Petit-Turcotte","year":"2001","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib21","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/clinchem\/27.4.543","article-title":"Quantitative determination of apolipoproteins C-I and C-II in human plasma by separate electroimmunoassays","volume":"27","author":"Curry","year":"1981","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0022-2275(20)43176-1","article-title":"Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI","volume":"31","author":"Hixson","year":"1990","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib23","doi-asserted-by":"crossref","first-page":"7277","DOI":"10.1016\/S0021-9258(18)68638-7","article-title":"Two copies of the human apolipoprotein C-I gene are linked closely to the apolipoprotein E gene","volume":"263","author":"Lauer","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0006-2944(80)90017-4","article-title":"Human apolipoprotein C-I: concentration in blood serum and lipoproteins","volume":"24","author":"Polz","year":"1980","journal-title":"Biochem Med"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib25","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000166784","article-title":"Effect of protein-reduced diet on plasma lipids, apolipoproteins and lipolytic activities in patients with chronic renal failure","volume":"4","author":"Attman","year":"1984","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0021-9150(86)90063-8","article-title":"Metabolism of apolipoprotein C-I in normolipoproteinemic human subjects","volume":"62","author":"Malmendier","year":"1986","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1203\/00006450-198519040-00013","article-title":"The serum apolipoprotein profile of patients with glucose-6- phosphatase deficiency","volume":"19","author":"Alaupovic","year":"1985","journal-title":"Pediatr Res"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib28","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000057457","article-title":"Apolipoprotein C-III, hypertriglyceridemia and triglyceride-rich lipoproteins in uremia","volume":"25","author":"Moberly","year":"1999","journal-title":"Miner Electrolyte Metab"},{"issue":"Suppl. 2","key":"10.1016\/j.atherosclerosis.2004.10.032_bib29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2337\/diab.41.2.S18","article-title":"Identification of apoB-containing lipoprotein families in NIDDM","volume":"41","author":"Alaupovic","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib30","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s001250051366","article-title":"Triglycerides, apo C3 and Lp B:C3 and cardiovascular risk in type II diabetes","volume":"43","author":"Gervaise","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib31","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1161\/01.ATV.14.12.1906","article-title":"Effects of lovastatin on apoA-I and apoB-containing lipoproteins: families in a subpopulation of patients participating in the monitored atherosclerosis regression study (MARS)","volume":"14","author":"Alaupovic","year":"1994","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib32","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0022-2275(20)37594-5","article-title":"Apolipoproteins C3 and E in apoB- and non-apo B-containing lipoproteins in two populations at contrasting risk for myocardial infarction: the ECTIM study","volume":"37","author":"Luc","year":"1996","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib33","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0021-9150(99)00151-3","article-title":"The effect of aggressive and moderate lowering of LDL-cholesterol and low-dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial","volume":"146","author":"Alaupovic","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2004.10.032_bib34","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1161\/01.CIR.102.16.1886","article-title":"VLDL, apolipoproteins B, CIII, and E and risk of recurrent coronary events in the cholesterol and recurrent events (CARE) trial","volume":"102","author":"Sacks","year":"2000","journal-title":"Circulation"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915004005696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915004005696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T15:35:07Z","timestamp":1625153707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915004005696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0021915004005696"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2004.10.032","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}